Travel Vaccines Market

Travel Vaccines Market is valued at USD 4.25 Billion in 2018 and expected to reach USD 7.10 Billion by 2025 with the CAGR of 7.6% over the forecast period.

Increasing awareness about vaccine preventable diseases and rise in global travel traffic are some of the factors which are driving the growth of Global Travel Vaccines Market.

Scope of the Travel Vaccines Market Report:

Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the world which helps to protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it'll protect against. The body responds to the vaccination by making antibodies which will protect it against a situation where there's an exposure to the disease within the future. Travel vaccinations are an important part of holiday and travel planning. Nowadays, travellers can protect themselves from endemic diseases by receiving the proper vaccinations, depending on where they want to go. Travel vaccines basically work in the same manner as regular vaccines. Vaccines, or immunizations, are solutions that provide immunity for a given disease. They protect travelers from illnesses that are usually travel-related. For example, a typhoid vaccine can prevent typhoid, a serious disease spread by contaminated food and water.

Global travel vaccines market report is segmented on the basis of product type, application and regional & country level. Based upon product type, travel vaccines market is classified into mono vaccines and combination vaccines. Based upon application, travel vaccines market is classified into domestic travel and outbound travel.

The regions covered in this Global travel vaccines market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level market of Travel Vaccines is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Travel Vaccines Companies:

Global travel vaccines Market Report covers prominent players are like,

• Pfizer, Sanofi
• GlaxoSmithKline
• Merck
• AstraZeneca
• Janssen Pharmaceuticals
• Abbott
• Mitsubishi Tanabe Pharma
• LG Life Sciences
• Roche
• Lupin
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• SK Chemicals
• Hualan Biological Engineering
• Indian Immunologicals
• Serum Institute of India
• GlycoVaxyn
• Beijing Minhai Biotechnology
• Shenzhen Kangtai Biological Products
• Others.

 

 

Increasing Awareness about Vaccine Preventable Diseases and Rise in Global Travel Traffic are Major Factors Driving the Market Growth.

The driving factors for the growth of travel vaccines market comprise increase in awareness about vaccine preventable diseases and rising global travel traffic. A significant number of these travelers moved from developed countries to regions with endemic diseases. According to World health Organization, International travel is on the rise, as millions of people travel for professional, social, recreational and humanitarian purposes each year. As more people travel to countries with endemic disease, demand for vaccinations will continue to increase. According to National Institutes of Health, Awareness of vaccine-preventable diseases among adults aged more than 19 years ranged from 63.4% to 94.0%. Awareness of the corresponding vaccines among adults aged are of following such as 63.4% reported awareness of HPV, 71.5% of tetanus, 72.0% of pertussis, 75.4% of HZ, 75.8% of hepatitis B, 83.1% of pneumonia, and 94.0% of influenza. Travel clinics offer vaccinations at a slightly higher price and new vaccines are usually more expensive are the factors which may hamper the market growth. Moreover, innovation of novel vaccine technologies and technological advancements towards molecular genetics can provide an opportunity for the further growth of global travel vaccines market in upcoming years.

North America is Expected to Dominate the Global Travel Vaccines Market

North America is expected to dominate the global travel vaccines market due to, rising occurrence of infectious and travel-related diseases such as diphtheria, meningitis, hepatitis B and yellow fever in this region. According to Hepatitis B Foundation, Up to 80,000 Americans will become newly infected with hepatitis B annually. The Centers for Disease Control reports states that 0.8 cases per 100,000 doses of yellow fever vaccine administered.

Europe is expected to hold the second largest share of this market attributed to the increasing prevalence of infectious diseases in this region. According to U.K. Trends in Infectious Disease, Infectious diseases are a significant health and economic burden in the UK, accounting for 7% of deaths and annual costs of Euro 30Billion. And the center of disease control and prevention stated that the 25,000 persons in the United Kingdom are infected with HIV, an overall prevalence of approximately 45 per 100,000 populations. At least 15,000 are receiving care.

Key Benefits for Global Travel Vaccines Market Report–

Global market report covers in depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Travel Vaccines Market Segmentation:–

By Product Type: Mono Vaccines, Combination Vaccine

By Application: Domestic Travel, Outbound Travel

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa